≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Mental and behavioural disorders of puerperium, not classified elsewhere

DOID Endpoint Browser

KRA_PSY_PUERPER

postpartum depression: An endogenous depression that involves intense, sustained and sometimes disabling depression experienced by women after giving birth.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F53
  • Hospital discharge: ICD-8 — 29440
  • Cause of death: ICD-10 — F53
  • Cause of death: ICD-8 — 29440

2 out of 7 registries used, show all original rules.

425

4. Check minimum number of events

None

425

5. Include endpoints

None

425

6. Filter based on genotype QC (FinnGen only)

425

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F50-F59
Name in latin
Perturbationes mentis et modi se gerendi puerperio adjunctae non alibi classificatae

Similar endpoints

↥

List of similar endpoints to Mental and behavioural disorders of puerperium, not classified elsewhere based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 425 425 -
Unadjusted period prevalence (%) 0.14 0.14 -
Median age at first event (years) 30.32 30.32 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
388
Matched controls
3879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F53.0
ICD-10 Finland
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
2851.3
186.1
165
*
F53.1
ICD-10 Finland
Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
123.7
112
*
29440
ICD-8 Finland
Psychosis associated with other physical conditions, Childbirth
+∞
80.0
74
*
N05AH04
ATC
quetiapine; oral
7.6
66.6
196
458
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
12.3
66.0
130
153
F53.9
ICD-10 Finland
Puerperal mental disorder, unspecified
+∞
65.5
61
*
N05AH03
ATC
olanzapine; systemic
11.9
53.1
104
116
N05BA04
ATC
oxazepam; oral
5.4
49.9
205
667
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
15.2
44.0
75
60
F29
ICD-10 Finland
Unspecified nonorganic psychosis
13.2
40.2
73
67
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.6
32.1
132
389
N06AB06
ATC
sertraline; oral
4.9
29.8
112
298
N05AX08
ATC
risperidone; systemic
7.6
29.5
73
115
N05AB03
ATC
perphenazine; systemic, rectal
11.6
27.0
51
50
N03AG01
ATC
valproic acid; systemic, rectal
6.3
25.5
72
135
N05AX12
ATC
aripiprazole; systemic
6.5
23.5
64
114
N05AN01
ATC
lithium; oral
11.1
23.0
44
44
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
8.7
22.3
49
63
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.0
22.0
101
316
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
10.5
20.9
41
43
N05BA06
ATC
lorazepam; systemic, sublingual
9.2
20.8
44
53
N05AA01
ATC
chlorpromazine; systemic, rectal
24.0
20.7
29
13
N05CD07
ATC
temazepam; oral
5.6
20.3
62
127
N05AD01
ATC
haloperidol; systemic
15.7
19.8
32
22
N05AA02
ATC
levomepromazine; systemic
7.7
19.1
45
65
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
10.6
18.6
36
37
N06AB04
ATC
citalopram; systemic
2.9
18.4
139
619
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
18.0
93
317
F53.8
ICD-10 Finland
Other mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
17.8
17
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
9.1
17.1
36
43
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.5
16.9
52
107
O99.80
ICD-10 Finland
The fear of childbirth
3.7
16.7
78
244
N06AX11
ATC
mirtazapine; oral
2.6
16.5
165
858
N05CF01
ATC
zopiclone; oral
2.8
16.5
136
633
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.4
16.5
63
164
N05AC02
ATC
thioridazine; oral
11.5
16.3
30
28
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.8
16.1
41
66
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.0
15.8
68
197
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.9
15.7
53
121
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
10.7
15.2
29
29
ZY000
NOMESCO Finland
Hospital inpatient
14.0
14.9
25
19
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
6.1
14.2
39
70
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.8
14.0
102
435
P76
ICPC
Depressive disorder
3.7
13.9
64
196
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
13.6
77
277
N06AX16
ATC
venlafaxine; oral
2.8
13.2
100
434
N04AA02
ATC
biperiden; systemic
9.9
13.2
26
28
N06AB03
ATC
fluoxetine; oral
3.0
13.0
81
310
P01
ICPC
Feeling anxious/nervous/tense
2.9
12.9
90
371
Z2446
NOMESCO Finland
Social worker
4.3
12.6
48
124
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.2
12.3
206
1325
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
13.0
12.3
21
17
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
11.6
12.2
22
20
P29
ICPC
Psychological sympt/compl other
3.6
11.4
53
163
N05AF03
ATC
chlorprothixene; systemic
6.2
11.3
30
52
SPAT1240
SPAT
Therapeutic discussion
2.7
10.9
82
352
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.2
10.8
147
850
N06AB05
ATC
paroxetine; oral
3.6
10.6
49
150
F20.9
ICD-10 Finland
Schizophrenia, unspecified
9.6
10.6
21
23
N03AX09
ATC
lamotrigine; oral
3.5
10.5
49
152
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.8
10.2
28
51
F31.8
ICD-10 Finland
Other bipolar affective disorders
6.4
10.2
26
43
O80.0
ICD-10 Finland
Spontaneous vertex delivery
2.0
10.1
211
1443
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
41.2
10.0
12
*
P06
ICPC
Sleep disturbance
3.1
9.9
57
206
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
8.7
9.7
20
24
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
7.5
9.6
22
31
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
18.1
9.5
14
8
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.7
9.4
26
48
P74
ICPC
Anxiety disorder/anxiety state
4.2
9.3
35
90
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
8.0
9.2
20
26
ZY010
NOMESCO Finland
Hospital outpatient
3.4
9.2
44
139
R3110
NOMESCO Finland
Psychosocial training
5.9
9.2
25
45
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.4
9.1
23
38
P99
ICPC
Psychological disorders other
4.8
9.0
29
64
N05AF05
ATC
zuclopenthixol; systemic
19.1
9.0
13
7
N06AB10
ATC
escitalopram; oral
2.1
8.8
123
707
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.7
8.4
36
104
P72
ICPC
Schizophrenia
8.8
8.4
17
20
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.3
8.3
81
395
N06AA12
ATC
doxepin; systemic
4.5
8.2
28
66
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
34.1
8.1
10
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.9
8.0
138
856
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
11.1
7.9
14
13
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.3
7.8
82
412
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
6.1
7.8
20
34
W78
ICPC
Pregnancy
1.9
7.7
132
813
188
Kela drug reimbursment
Psychosis requiring demanding treatment
10.3
7.6
14
14
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
81.6
7.4
8
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.3
7.3
68
322
29999
ICD-8 Finland
Unspecified psychosis
16.1
7.3
11
7
F51.0
ICD-10 Finland
Nonorganic insomnia
2.2
7.2
78
397
N06AX03
ATC
mianserin; oral
4.1
7.1
26
66
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
2.0
7.0
97
547
N05BA01
ATC
diazepam; systemic, rectal
2.6
6.9
53
226
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
6.9
34
111
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
2.1
6.9
80
419
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
6.9
6.9
16
24
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
9.6
6.8
13
14
N06AA22
ATC
NA
40.8
6.8
8
*
SPAT1197
SPAT
Extensive health check-up of expecting family
1.9
6.7
113
688
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
10.3
6.6
12
12
T90
ICPC
Diabetes non-insulin dependent
2.4
6.5
56
255
ZYC01
NOMESCO Finland
Remote contact by phone
3.3
6.4
31
100
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.1
6.4
79
425
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
71.0
6.4
7
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.8
6.4
41
159
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.3
6.4
18
35
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
8.4
6.4
13
16
N05BA12
ATC
alprazolam; oral
2.4
6.3
52
232
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
27.1
6.2
8
*
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
27.1
6.2
8
*
A06AD11
ATC
lactulose; oral
2.7
6.2
40
156
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
6.5
6.2
15
24
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.9
6.2
24
65
G02CB01
ATC
bromocriptine; systemic
4.2
6.2
22
55
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
6.2
44
183
Z37.0
ICD-10 Finland
Single live birth
2.0
6.2
88
503
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.6
6.2
26
76
AA400
NOMESCO Finland
Electroconvulsive therapy
12.8
6.1
10
8
N06AX12
ATC
bupropion; oral
2.4
6.1
49
218
N05AL01
ATC
sulpiride; systemic
10.2
6.1
11
11
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.2
6.0
63
317

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
106
501
2.49
13.58
1.8
1.6
%
1.4
1.3
1.71
96
458
(3015377) Calcium [Moles/volume] in Serum or Plasma
171
1006
2.17
13.01
2.5
2.8
mmol/l
2.3
2.3
0.52
158
910
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
204
1332
2.02
11.34
5.1
5.1
mmol/l
1.2
1.2
0.24
170
1119
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
319
2467
2.18
10.87
6.0
6.3
u/l
69.6
72.8
1.29
309
2309
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
593
2.21
10.80
1.8
1.5
pmol/l
434.0
42938272.7
1.08
101
531
(3019309) Folate [Moles/volume] in Red Blood Cells
82
405
2.27
9.25
1.7
1.6
nmol/l
1271.3
1167.8
0.38
67
315
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
23
6.26
8.23
3.5
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
235
1746
1.77
7.67
4.4
3.6
mmol/l
6.3
6.2
0.31
210
1552
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
173
1179
1.79
7.58
4.9
4.4
mmol/l
1.2
1.2
0.39
157
1075
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1187
1.77
7.36
2.9
2.9
u/l
28.6
27.8
0.14
164
1139
(3021960) Folate [Moles/volume] in Serum or Plasma
105
620
1.92
7.23
1.6
1.4
nmol/l
20.6
21.5
0.28
95
548
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
163
1106
1.77
7.16
1.8
1.8
pmol/l
99.3
98.3
0.11
94
600
(3044640) Blood type and Crossmatch panel - Blood
161
1095
1.76
6.97
1.8
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
422
2.04
6.88
2.3
2.1
u/l
5970.4
5190.3
0.09
35
185
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
378
3309
2.29
6.87
4.4
3.4
mmol/l
5.7
5.6
0.86
355
3105
(3026008) Bacteria identified in Urine by Culture
147
985
1.75
6.65
3.0
2.2
—
—
—
0
0
(4198724)
12
21
5.85
6.62
1.7
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
31
114
2.85
6.43
2.7
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
308
2555
1.75
6.09
3.3
2.7
u/l
32.0
32.9
0.13
295
2447
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
927
1.69
5.62
2.7
2.6
ng/l
20.7
18.2
0.11
59
401
(3023368) Bacteria identified in Blood by Culture
93
569
1.81
5.62
4.0
3.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
292
2411
1.67
5.62
5.3
3.8
e6/l
7021.0
929.3
—
5
29
(3019550) Sodium [Moles/volume] in Serum or Plasma
386
3467
2.24
5.60
12.5
9.0
mmol/l
139.3
139.6
1.64
381
3370
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
356
3111
1.89
5.55
6.2
4.5
pmol/l
14.0
14.2
1.20
342
2942
(3023103) Potassium [Moles/volume] in Serum or Plasma
386
3477
2.20
5.39
12.9
9.1
mmol/l
3.9
3.9
0.17
379
3365
(3026782) Osmolality of Urine
88
539
1.80
5.28
2.9
2.3
mosm/kgh2o
519.8
537.3
0.22
76
455
(3002032) Base excess in Venous blood by calculation
35
154
2.39
5.11
2.3
3.6
mmol/l
0.9
1.8
0.52
25
120
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
195
1482
1.58
5.09
2.2
2.2
nmol/l
72.7
74.1
0.35
182
1376
(3018418) pH of Serum or Plasma
118
796
1.67
4.99
4.1
3.3
ph
7.4
7.4
0.09
24
149
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
952
1.63
4.98
3.2
2.3
u/l
53.6
55.0
0.21
121
887
(3024561) Albumin [Mass/volume] in Serum or Plasma
157
1151
1.58
4.69
4.3
4.0
g/l
36.1
37.2
1.73
147
1080
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
303
1.94
4.57
3.5
3.7
pmol/l
4.5
4.7
0.51
46
269
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
396
3651
2.24
4.41
12.5
9.6
mg/l
19.2
17.4
0.52
319
2760
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
386
3527
2.03
4.39
7.2
5.1
mu/l
1.6
2.0
0.78
371
3354
(3044889) 12 lead EKG panel
256
2114
1.53
4.34
3.1
2.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
137
994
1.56
4.20
3.8
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
145
1066
1.55
4.19
5.4
5.4
—
—
—
0
0
(3019225) pH of Specimen
48
261
1.95
4.15
3.2
3.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
812
1.59
4.15
1.7
2.0
mg/l
2.8
2.8
0.02
96
695
(3011397) Hemoglobin [Presence] in Urine by Test strip
109
753
1.60
4.11
4.3
3.0
—
—
—
0
0
(3015736) pH of Urine
181
1401
1.51
4.10
4.0
2.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
302
2601
1.56
4.09
3.6
3.7
mm/h
10.6
8.9
1.99
288
2438
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
220
1775
1.50
4.06
4.8
3.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
59
346
1.82
4.06
1.4
2.0
nmol/l
380.4
375.0
0.07
51
319
(3024354) Oxygen [Partial pressure] in Venous blood
29
132
2.28
3.96
2.3
2.6
kpa
5.4
4.7
1.04
29
132
(3035350) Ketones [Presence] in Urine by Test strip
220
1781
1.49
3.95
4.6
3.0
estimate
0.0
0.0
0.00
46
377
(3019150) Specific gravity of Urine by Refractometry
108
751
1.59
3.95
5.3
3.1
kg/l
1.0
1.0
0.09
16
105
(3011288) Drugs identified in Urine by Screen method
36
180
2.09
3.92
3.8
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
87
576
1.64
3.88
3.0
2.3
e6/l
8.0
10.2
0.59
75
502
(3006315) Basophils [#/volume] in Blood
217
1758
1.48
3.85
6.1
5.2
e9/l
0.0
0.0
0.33
188
1554
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
199
1585
1.48
3.85
4.6
4.9
umol/l
9.0
9.4
0.39
189
1490
(3001604) Monocytes [#/volume] in Blood
216
1752
1.47
3.79
6.0
5.2
e9/l
0.5
0.5
0.83
187
1554
(3013650) Neutrophils [#/volume] in Blood by Automated count
242
2011
1.47
3.73
9.7
7.7
e9/l
4.2
3.9
1.33
215
1763
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
279
1.85
3.70
2.5
2.3
u/l
36.7
31.9
0.26
44
236
(3037467) Urinalysis macro (dipstick) panel - Urine
292
2522
1.50
3.68
4.9
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
117
842
1.54
3.66
3.3
2.6
e6/l
14.0
43.0
2.02
96
616
(3026389) Candida sp identified in Specimen by Organism specific culture
13
40
3.32
3.65
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
146
1102
1.49
3.64
3.7
3.0
e6/l
24.5
53.4
1.09
99
681
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
145
2.15
3.57
1.7
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
223
1834
1.45
3.56
6.4
5.5
e9/l
0.2
0.2
0.30
199
1646
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
822
1.53
3.52
1.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
147
1123
1.47
3.42
1.9
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
461
1.65
3.41
1.9
2.1
mmol/l
2.4
2.4
0.22
63
400
(3019069) Monocytes/100 leukocytes in Blood
203
1650
1.44
3.40
5.7
5.4
%
7.8
7.8
0.09
194
1554
(40758558) Short blood count panel - Blood
115
837
1.51
3.38
5.6
5.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
130
971
1.49
3.37
1.8
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
14
48
2.98
3.33
2.1
2.6
mmol/l
22.5
23.8
0.37
14
42
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
374
3443
1.72
3.30
3.9
3.5
mmol/l
4.8
4.8
0.07
348
3284
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
373
3432
1.71
3.29
3.8
3.4
mmol/l
1.5
1.6
4.31
349
3264
(3019198) Lymphocytes [#/volume] in Blood
220
1822
1.43
3.29
6.3
5.2
e9/l
2.1
2.0
0.17
195
1645
(3021601) Nitrite [Presence] in Urine by Test strip
216
1784
1.43
3.27
5.5
4.2
estimate
0.0
0.0
0.50
49
385
(3003694) ABO and Rh group [Type] in Blood
169
1335
1.44
3.27
1.8
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
218
1805
1.43
3.25
4.5
3.1
estimate
0.0
0.0
0.50
48
375
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
37
201
1.92
3.24
5.9
3.3
mmol/l
1.2
1.2
0.75
28
170
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3788
2.13
3.23
10.0
8.2
u/l
22.4
23.6
1.07
396
3683
(3001122) Ferritin [Mass/volume] in Serum or Plasma
245
2077
1.42
3.17
3.2
2.9
ug/l
63.6
58.5
0.31
232
1970
(3029937) Albumin [Presence] in Urine by Test strip
127
957
1.47
3.12
5.3
3.2
estimate
0.0
0.0
0.80
46
384
(3000764) Benzodiazepines [Presence] in Urine
44
256
1.80
3.12
2.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
62
398
1.65
3.11
3.4
2.5
mmol/l
0.8
0.8
3.16
57
380
(3007853) Bacteria identified in Skin by Aerobe culture
56
350
1.69
3.11
1.9
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
192
1566
1.41
3.06
8.7
7.3
e9/l
0.0
0.0
0.66
153
1298
(3006504) Eosinophils/100 leukocytes in Blood
200
1643
1.41
3.06
5.5
5.2
%
2.6
2.7
0.06
189
1534
(3028300) Cannabinoids [Presence] in Urine
44
258
1.79
3.05
2.5
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
206
1702
1.41
3.04
5.8
5.0
%
56.6
56.5
0.05
194
1599
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
121
2.13
2.99
1.8
3.1
mmol/l
2.3
1.0
0.48
15
85
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
86
603
1.53
2.99
2.4
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
128
2.10
2.98
5.8
7.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
208
1.85
2.93
2.6
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
207
1719
1.40
2.93
5.4
5.2
%
30.1
29.8
0.12
196
1615
(3027008) Opiates [Presence] in Urine
43
256
1.76
2.84
2.3
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
374
3472
1.64
2.83
4.2
3.7
mmol/l
2.9
2.9
0.24
346
3292
(3016879) Cocaine [Presence] in Urine
40
235
1.78
2.77
2.5
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
191
1579
1.38
2.72
5.6
5.3
%
0.6
0.7
0.36
181
1472
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
357
3287
1.54
2.71
3.5
3.1
mmol/l
1.3
1.2
3.03
333
3115
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
68
464
1.55
2.66
1.9
2.5
ng/l
605.2
553.0
0.08
51
374
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
127
2.03
2.66
1.8
3.1
kpa
5.0
5.1
0.16
25
120
(3003458) Phosphate [Moles/volume] in Serum or Plasma
45
277
1.70
2.65
6.2
4.8
mmol/l
1.1
1.0
0.68
40
258
(3030467) Casts [#/volume] in Urine by Automated count
101
753
1.45
2.58
3.4
2.5
e6/l
0.2
0.3
0.34
83
544
(3017143) Hepatitis C virus Ab [Presence] in Serum
84
604
1.49
2.58
1.7
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
218
1.76
2.55
1.4
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
21
3.86
2.47
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
171
1406
1.36
2.46
4.7
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
164
1346
1.36
2.36
2.4
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
224
1.71
2.33
1.4
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
24
128
1.93
2.26
1.4
2.2
umol/l
4.4
5.0
0.37
19
95
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
326
2983
1.40
2.24
5.4
4.1
mmol/mol
37.5
37.4
0.13
309
2831
(3027944) Amphetamines [Presence] in Urine
40
252
1.65
2.19
2.4
1.4
—
—
—
0
0
(3013512) EKG study
95
723
1.40
2.15
3.1
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
101
777
1.39
2.15
3.3
2.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
102
2.01
2.14
1.2
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
37
231
1.66
2.10
1.9
2.3
g/l
0.2
0.2
0.46
32
225
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
17
82
2.12
2.09
3.3
3.3
%
54.0
50.0
0.23
17
82
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
89
2.07
2.09
1.6
2.5
%
1.6
1.2
0.47
18
89
(3022948) Iron [Moles/volume] in Serum or Plasma
62
441
1.48
2.02
2.8
2.1
umol/l
14.1
15.0
0.37
57
404
(21494755) Public health laboratory ask at order entry panel
38
574
0.63
2.01
1.3
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
32
2.85
2.01
1.7
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
358
1.52
1.98
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
358
1.52
1.98
1.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
101
791
1.36
1.92
3.8
3.0
mmol/l
6.3
7.6
2.32
84
684
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
85
648
1.39
1.91
1.5
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
31
190
1.68
1.90
2.6
3.4
ng/l
70.0
74.7
0.15
26
174
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
431
1.46
1.86
1.3
1.3
iu/l
25.1
24.4
0.05
52
374
(3004789) Transferrin [Mass/volume] in Serum or Plasma
55
389
1.48
1.85
2.9
2.1
g/l
2.7
2.5
1.09
46
358
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
272
1.56
1.85
1.1
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
339
1.50
1.83
3.0
2.2
%
21.5
24.5
0.67
42
285
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
35
2.60
1.81
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
374
1.48
1.80
1.5
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
1058
1.31
1.79
1.4
1.3
u/ml
0.6
2.0
1.92
47
298
(3000494) Fungus identified in Specimen by Culture
52
367
1.48
1.77
1.5
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
353
3315
1.38
1.73
9.8
7.9
ml/min/173m2
93.7
93.3
0.13
287
2657
(3024928) Oxygen saturation in Venous blood
8
30
2.70
1.73
1.5
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
30
2.70
1.73
1.9
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
1.0
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
24
2.95
1.73
1.1
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
126
1036
1.31
1.71
2.7
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
119
1.80
1.69
2.4
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
320
1.49
1.69
8.2
4.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
26
158
1.69
1.66
4.6
7.1
%
97.0
96.6
0.35
26
153
(3006653) Thiamine [Moles/volume] in Blood
5
14
3.60
1.62
1.2
1.6
nmol/l
156.4
148.1
—
5
14
(3014007) Fractional oxyhemoglobin in Arterial blood
18
99
1.85
1.60
5.4
8.0
%
94.9
94.7
0.09
18
99
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
92
1.88
1.58
1.7
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
770
1.32
1.55
1.8
1.9
u/l
240.5
210.2
0.07
91
733
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
138
1.70
1.55
1.3
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
419
4110
2.38
1.55
20.9
14.7
e9/l
272.2
268.3
0.60
413
4040
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
27
2.62
1.52
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
402
3888
1.63
1.48
13.1
9.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
87
1.87
1.48
1.8
3.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
45
2.25
1.47
1.8
2.8
ug/min
21.6
123.2
—
5
30
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
38
2.40
1.46
1.1
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
339
1.43
1.46
4.9
3.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
109
899
1.29
1.43
5.2
5.2
inr
1.0
1.0
1.62
33
322
(3026361) Erythrocytes [#/volume] in Blood
419
4113
2.33
1.42
20.8
14.6
e12/l
4.4
4.5
2.04
410
4034
(3050129) First trimester maternal screen panel - Serum or Plasma
57
428
1.38
1.42
1.5
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
166
1.60
1.41
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
60
2.03
1.39
1.1
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
41
291
1.45
1.39
1.5
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
25
159
1.61
1.38
12.5
8.2
mmol/l
7.1
6.8
0.10
25
154
(3047352) Trisomy 18 risk [Likelihood] in Fetus
41
292
1.45
1.37
1.5
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
28
184
1.56
1.35
4.7
6.5
mmol/l
0.4
1.2
0.51
22
139
(3001019) Free T4 and TSH panel - Serum or Plasma
28
412
0.66
1.35
2.1
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
432
1.37
1.34
1.3
1.2
iu/ml
77.3
161.4
1.87
29
182
(1616796) Gas panel - Central venous blood
10
47
2.15
1.34
2.9
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
268
1.46
1.33
3.0
2.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
419
4115
2.29
1.29
20.9
14.7
e9/l
7.0
6.7
2.34
412
4032
(40761535) Cells panel - Urine sediment
32
220
1.49
1.28
4.9
3.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
51
385
1.37
1.24
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
239
1.46
1.22
2.6
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
47
351
1.38
1.22
2.0
2.4
umol/l
4.7
4.9
0.13
38
304
(3043238) Trisomy 21 risk [Likelihood] in Fetus
41
299
1.41
1.22
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
42
308
1.40
1.21
1.4
1.5
mu/l
476.2
283.9
1.03
37
269
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
165
1.55
1.20
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
240
1.45
1.20
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
113
957
1.25
1.19
4.8
3.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
87
1.75
1.16
4.8
8.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
311
1.39
1.15
1.6
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
30
2.35
1.13
1.0
1.5
—
—
—
0
0
(3000492) Spirometry study
25
361
0.67
1.12
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
1.0
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
31
220
1.44
1.08
2.7
2.5
%
1.6
1.8
0.93
24
194
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
82
1.73
1.06
1.5
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
22
2.29
1.03
1.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
22
2.29
1.03
2.0
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
945
1.22
1.01
2.7
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
105
899
1.22
0.99
1.4
1.4
g/l
2.2
2.0
0.91
67
579
(1761482) Bacteria [#/volume] in Urine by Culture
9
50
1.82
0.97
2.6
3.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
80
667
1.25
0.97
5.2
4.1
mg/mmol
17.3
9.9
0.24
49
415
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
32
0.00
0.95
0.0
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
101
1.61
0.95
9.1
1.9
g/l
3.6
3.6
0.05
16
96
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
37
1.91
0.94
1.1
1.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
26
184
1.44
0.94
4.9
6.5
kpa
12.4
13.4
0.69
26
177
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
26
184
1.44
0.94
4.9
6.5
kpa
5.3
5.1
0.55
26
177
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
273
1.35
0.89
1.5
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
103
1.58
0.88
2.1
3.2
g/l
0.4
0.4
—
5
33
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
274
1.34
0.87
1.7
1.4
—
—
—
0
0
(44790048)
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(44790049)
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(44806118)
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(44790047)
6
30
2.01
0.87
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
80
1.64
0.85
1.4
1.4
—
—
—
0
0
(44813793)
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
57
1.77
0.84
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
87
744
1.21
0.84
1.3
1.3
iu/ml
14.3
25.6
2.37
29
238
(3012516) Albumin [Mass/volume] in Urine
76
641
1.23
0.84
3.9
3.3
mg/l
112.3
171.7
0.18
43
412
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
366
1.29
0.83
1.5
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
30
225
1.36
0.80
1.5
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
123
1.48
0.79
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
140
1.45
0.78
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
307
1.30
0.77
1.6
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
75
1.62
0.75
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
24
2.10
0.74
1.0
1.1
miu/ml
1208.0
1797.5
—
5
24
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
132
1185
1.17
0.74
1.8
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
29
220
1.34
0.74
11.9
9.1
inr
1.3
1.1
—
6
48
(3041354) Potassium [Moles/volume] in Venous blood
5
25
2.01
0.73
1.2
2.4
mmol/l
3.9
3.8
—
5
25
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
25
2.01
0.73
1.2
2.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
25
2.01
0.73
1.2
2.4
mmol/l
108.2
105.4
—
5
25
(3045414) Leukocytes [Presence] in Urine
20
143
1.42
0.71
1.7
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
126
1.45
0.71
1.1
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
26
1.93
0.71
3.0
1.2
pg
33.6
32.5
—
5
26
(3003327) Ova and parasites identified in Stool by Light microscopy
23
170
1.37
0.69
1.6
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
96
845
1.18
0.68
1.6
1.6
mmol/l
1.4
1.3
0.12
82
744
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
42
1.68
0.68
1.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
42
1.68
0.68
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
43
1.64
0.67
2.7
2.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
28
1.79
0.66
3.2
3.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
78
1.55
0.66
1.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
44
1.60
0.65
1.0
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
830
1.17
0.65
2.0
1.7
mg/l
1.0
0.7
0.77
70
610
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
85
745
1.18
0.64
1.2
1.3
u/ml
6.2
10.6
0.42
38
324
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
253
1.29
0.63
1.6
1.6
—
—
—
0
0
(3020891) Body temperature
11
71
1.56
0.62
5.8
4.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
46
381
1.23
0.62
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
336
3247
1.17
0.62
16.4
11.4
%
13.4
13.5
0.72
329
3201
(3026493) Urate [Moles/volume] in Serum or Plasma
84
738
1.17
0.62
2.3
2.2
umol/l
4052.4
3611.1
0.04
72
669
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
419
1.22
0.61
2.1
2.8
ng/l
155.7
404.3
0.47
21
205
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
78
682
1.18
0.61
1.4
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
122
1.41
0.61
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
68
591
1.18
0.57
1.3
1.4
titre
1053.3
576.8
—
9
117
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
81
1.50
0.57
1.4
2.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
36
1.68
0.57
2.2
3.5
mu/l
24.1
25.5
—
6
36
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
60
1.51
0.54
1.7
1.8
ug/l
311.9
200.3
—
9
49
(3045424) Erythrocytes [Presence] in Urine
9
60
1.51
0.54
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
74
1.50
0.54
1.5
1.3
u/ml
69.2
118.5
—
5
18
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
62
1.46
0.53
1.2
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
135
0.66
0.52
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
83
1.46
0.52
2.7
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
399
1.20
0.52
2.5
2.3
e6/l
5.0
4.5
0.09
28
199
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
474
0.83
0.51
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
135
1249
1.12
0.48
1.4
1.5
—
—
—
0
0
(4010399)
15
199
0.74
0.47
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
164
1.30
0.47
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
118
1084
1.12
0.47
4.0
2.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
138
1.32
0.46
2.2
2.0
iu/l
5.4
5.5
—
7
52
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
165
1.29
0.46
1.5
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
50
1.41
0.45
1.3
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
51
1.38
0.44
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
369
1.18
0.44
1.9
1.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
56
1.44
0.42
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
64
569
1.15
0.42
1.9
2.3
ug/g
74.7
76.5
0.06
50
435
(3023520) Reticulocytes [#/volume] in Blood
19
149
1.29
0.42
2.5
2.4
e9/l
62.8
77.3
1.29
11
103
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
70
1.44
0.42
1.2
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
1.5
—
0
15
(3010503) CD19 cells [#/volume] in Blood
0
15
0.00
0.41
0.0
2.7
—
0.2
—
0
15
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
16
0.00
0.41
0.0
2.7
—
56.0
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
48
420
1.16
0.40
2.7
2.2
e6/l
0.6
1.0
0.64
29
221
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
80
1.38
0.38
1.2
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
11
80
1.38
0.38
1.8
3.5
mmol/l
24.9
24.6
0.08
11
80
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
67
1.35
0.38
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
98
1.34
0.38
1.2
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
244
1.20
0.37
1.5
1.4
miu/ml
190.4
256.3
0.46
17
130
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
342
0.84
0.37
1.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
149
1577
0.92
0.36
1.7
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
78
0.64
0.36
1.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
126
0.71
0.35
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
47
1.28
0.32
1.5
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
52
1.35
0.31
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
344
1.15
0.31
3.6
3.2
%
29.6
32.5
0.95
33
243
(4268621)
7
54
1.30
0.30
2.0
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
313
0.85
0.30
2.3
2.2
—
22.2
—
0
21
(4094501)
7
56
1.25
0.29
1.1
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
129
0.77
0.28
2.5
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
131
1.23
0.27
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
281
1.15
0.27
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
66
1.22
0.27
1.4
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
72
1.26
0.26
2.7
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
73
1.24
0.25
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
49
446
1.11
0.25
1.2
1.2
—
—
—
0
0
(4034850)
13
105
1.25
0.25
17.2
6.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
236
1.15
0.25
2.7
1.8
ml/min/173m2
71.0
83.2
0.70
14
91
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
12
96
1.26
0.24
1.2
1.3
mg/l
326.3
360.1
0.62
12
88
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
134
1.20
0.23
1.4
2.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
39
1.29
0.23
1.2
1.1
g/l
1.7
1.4
—
5
34
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
57
528
1.09
0.21
2.0
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
43
1.16
0.21
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
11
89
1.24
0.21
1.1
1.1
u/ml
2.3
1.9
—
6
46
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
8.1
—
0
13
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
676
1.08
0.20
2.3
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
316
3210
0.94
0.20
4.1
4.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
127
1.19
0.20
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
99
1.22
0.20
4.0
5.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
81
1.24
0.19
1.3
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
377
1.10
0.18
1.1
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
132
0.83
0.18
3.0
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
215
1.12
0.17
3.6
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
70
1.15
0.16
1.4
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
130
0.84
0.16
1.2
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
73
1.10
0.16
4.0
5.0
mmol/l
1.0
1.1
—
8
63
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
77
0.78
0.15
3.8
3.8
%
57.2
57.6
—
6
77
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
150
0.86
0.15
1.3
1.5
g/l
1.2
1.2
0.24
13
143
(3008898) HLA-B27 [Presence]
22
243
0.90
0.14
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
116
0.86
0.12
1.4
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
439
1.05
0.09
1.1
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
57
1.05
0.08
12.8
2.2
nmol/l
1.0
0.9
—
6
47
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
68
1.03
0.08
1.3
1.1
%
131.7
116.5
—
7
62
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
98
1.13
0.07
1.1
1.4
ug/g
274.8
335.7
—
5
50
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
75
0.80
0.07
3.5
3.5
e9/l
4.2
4.4
—
6
75
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
74
1.08
0.07
1.0
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
143
0.91
0.07
1.3
1.6
g/l
0.2
0.2
0.27
13
137
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
90
0.89
0.07
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
266
1.06
0.06
2.4
2.2
e9/l
4.1
4.1
0.01
19
230
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
284
0.95
0.06
1.2
1.3
—
20.0
—
0
11
(3020961) Endomysium IgA Ab [Titer] in Serum
25
237
1.06
0.06
1.0
1.1
—
152.5
—
0
8
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
283
0.95
0.05
1.0
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
259
1.05
0.04
6.2
3.9
%
0.8
1.0
—
8
63
(1002224) Polysomnography panel
19
180
1.06
0.04
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
355
3537
1.02
0.03
13.4
10.3
%
39.0
39.6
1.02
268
2932
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
16
151
1.06
0.03
1.3
1.4
ug/l
2.5
2.6
0.05
16
136
(3003740) Influenza virus B Ag [Presence] in Specimen
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
149
1481
1.01
0.01
2.6
2.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
330
3307
0.99
0.01
17.4
12.2
g/l
332.5
332.0
0.44
330
3284
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
124
1.05
0.00
1.5
1.9
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
125
0.96
0.00
1.2
1.3
—
34.2
—
0
8
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
125
1.04
0.00
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
241
1.00
0.00
5.5
3.9
%
0.4
0.8
—
7
42
(4035726)
24
243
0.99
0.00
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
235
1.02
0.00
6.7
4.0
%
0.0
0.2
—
7
45
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
174
0.98
0.00
2.7
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
25
246
1.02
0.00
6.6
4.0
%
0.0
0.1
—
7
57
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
59
0.85
0.00
1.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
18.6
—
0
6
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.1
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
3.5
—
314.7
—
0
6
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
82
0.98
0.00
1.5
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
54
0.93
0.00
1.4
2.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
6.4
2.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
50
1.00
0.00
1.4
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
63
0.95
0.00
1.2
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
3.0
—
5.2
—
0
5
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.2
—
174.1
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
(4306422)
7
69
1.01
0.00
1.3
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
75
0.93
0.00
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
79
1.01
0.00
1.3
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
7
0.00
0.00
0.0
3.0
—
7.0
—
0
7
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_PUERPER – Mental and behavioural disorders of puerperium, not classified elsewhere

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).